Effect of Aspirin on Melanoma Incidence in Older Persons: Extended Follow-up of a Large Randomized Double-blind Placebo-controlled Trial.
Mabel K YanSuzanne G OrchardNikki R AdlerRory WolfeCatriona McLeanLuz Maria RodriguezRobyn L WoodsPeter GibbsAndrew T ChanAndrew M HaydonVictoria J MarPublished in: Cancer prevention research (Philadelphia, Pa.) (2022)
Melanoma prevention is an important strategy to improve outcomes and while preventive efforts have largely focused on sun protection, the role of potential chemopreventive agents such as aspirin warrants investigation.
Keyphrases
- double blind
- placebo controlled
- low dose
- clinical trial
- phase iii
- cardiovascular events
- antiplatelet therapy
- phase ii
- skin cancer
- study protocol
- risk factors
- physical activity
- basal cell carcinoma
- anti inflammatory drugs
- community dwelling
- middle aged
- quality improvement
- open label
- acute coronary syndrome
- human health
- risk assessment
- percutaneous coronary intervention
- coronary artery disease
- insulin resistance
- cardiovascular disease
- adipose tissue